Celkeran (5 mg) [Chlorambucil]

Drug brand Celkeran (5 mg) is being manufactured and marketed by Celon Labs. The main active ingredient or salt in this drug is Chlorambucil. This drug comes in the form of Tablet. The general packing available for this medicine consists of 30 Tablet and is priced at Rs 2.00 (arround $0.028 US Dollar)

Generic :	Chlorambucil
Pharma Company :	Celon Labs
Brand Label :	Celkeran (5 mg)
Preparation Type :	Tablet
Single Dose :	1 Tablet
Composition :	Chlorambucil-5 mg
Pack Size/Qty/Vol :	30 Tablet
Price Unit :	Rs 81.67
Price Pack :	Rs 2.00 INR (arround $0.028 US Dollar)

Drug details for Celkeran (5 mg)

Usage: Why is this medication prescribed?

The main active ingredient or salt in Celkeran (5 mg) is Chlorambucil.

Chlorambucil is used treat a certain type of chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). Chlorambucil is also used to treat non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (types of cancer that begin in certain white blood cells that normally fight infection). Chlorambucil is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.

Celkeran (5 mg) - Chlorambucil - For more details on its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Celkeran (5 mg) - Chlorambucil..

Generic Drug Substitutes for : Celkeran (5 mg)

There are 2 brands listed here as Generic Substitutes for Celkeran (5 mg), which have same salt or similar Generic composition (i.e. Chlorambucil-5 mg).
Please note that one can request a doctor or pharmacist to substitute a generic version of the prescribed drug brand, if any. So far as quality and performance of generic version is concerned, mostly, Generics with the same active ingredient (here i.e. Chlorambucil-5 mg), are just as appropriate and effective for patient treatment as otherwise, the prescribed branded one

Brand	Price (Rs.)	Brand	Price (Rs.)
Chloramax (5 mg)	2.00	Leukeran (5 mg)	1.00

Search Drug Brands alphabetically